Insider Transactions Reported by 15 Insiders of CymaBay Therapeutics, Inc.

Location
Newark, CA

There are no Buy or Sell transactions made by insiders since 06 Jan 2025

CymaBay Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Avoro Capital Advisors LLC 10%+ Owner $9,999,939 12 Sep 2023
DENNIS D. KIM Chief Medical Officer $473,520 13 Apr 2023
KURT VON EMSTER Director $0 22 Mar 2024
Charles McWherter President of R&D $0 22 Mar 2024
Janet Dorling Director $0 22 Mar 2024
Harish Shantharam Chief Financial Officer $0 22 Mar 2024
Robert Wills Director $0 22 Mar 2024
Sujal Shah Chief Executive Officer, Director $0 22 Mar 2024
Paul Quinlan General Counsel $0 22 Mar 2024
Klara Dickinson Chief Regulatory Officer $0 22 Mar 2024
Eric Lefebvre Director 22 Mar 2024
THOMAS G. WIGGANS Director 22 Mar 2024
LEWIS J. STUART Chief Commercial Officer 25 Jan 2023
Daniel Menold Vice President, Finance 16 Jan 2024
Caroline M. Loewy Director 22 Mar 2024

Recent Insider Transactions by Companies or Individuals for CymaBay Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.